Perspective Therapeutics, Inc. AAJ.F Stock
Perspective Therapeutics, Inc. Price Chart
Perspective Therapeutics, Inc. AAJ.F Financial and Trading Overview
| Perspective Therapeutics, Inc. stock price | 1.29 EUR |
| Previous Close | 0.5 EUR |
| Open | 0.52 EUR |
| Bid | 0.52 EUR x 800000 |
| Ask | 0.53 EUR x 750000 |
| Day's Range | 0.52 - 0.52 EUR |
| 52 Week Range | 0.2 - 0.63 EUR |
| Volume | 100 EUR |
| Avg. Volume | 255 EUR |
| Market Cap | 144.27M EUR |
| Beta (5Y Monthly) | 1.571428 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.13 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.97 EUR |
AAJ.F Valuation Measures
| Enterprise Value | 101.81M EUR |
| Trailing P/E | N/A |
| Forward P/E | -25.75 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 23.056973 |
| Price/Book (mrq) | 1.2146226 |
| Enterprise Value/Revenue | 16.271 |
| Enterprise Value/EBITDA | -4.147 |
Trading Information
Perspective Therapeutics, Inc. Stock Price History
| Beta (5Y Monthly) | 1.571428 |
| 52-Week Change | 103.62% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.63 EUR |
| 52 Week Low | 0.2 EUR |
| 50-Day Moving Average | 0.54 EUR |
| 200-Day Moving Average | 0.38 EUR |
AAJ.F Share Statistics
| Avg. Volume (3 month) | 255 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 280.13M |
| Float | 277.75M |
| Short Ratio | N/A |
| % Held by Insiders | 0.76% |
| % Held by Institutions | 6.18% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -218.85% |
| Operating Margin (ttm) | -399.72% |
| Gross Margin | 10.86% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 6.26M EUR |
| Revenue Per Share (ttm) | 0.04 EUR |
| Quarterly Revenue Growth (yoy) | -29.099% |
| Gross Profit (ttm) | N/A |
| EBITDA | -24550000 EUR |
| Net Income Avi to Common (ttm) | -13694000 EUR |
| Diluted EPS (ttm) | -0.06 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 36.45M EUR |
| Total Cash Per Share (mrq) | 0.13 EUR |
| Total Debt (mrq) | 2.12M EUR |
| Total Debt/Equity (mrq) | 1.79 EUR |
| Current Ratio (mrq) | 5.597 |
| Book Value Per Share (mrq) | 0.424 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -20471000 EUR |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Perspective Therapeutics, Inc.
| Country | Germany |
| State | WA |
| City | Richland |
| Address | 350 Hills Street |
| ZIP | 99354 |
| Phone | 509-375-1202 |
| Website | https://www.perspectivetherapeutics.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.
Q&A For Perspective Therapeutics, Inc. Stock
What is a current AAJ.F stock price?
Perspective Therapeutics, Inc. AAJ.F stock price today per share is 1.29 EUR.
How to purchase Perspective Therapeutics, Inc. stock?
You can buy AAJ.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Perspective Therapeutics, Inc.?
The stock symbol or ticker of Perspective Therapeutics, Inc. is AAJ.F.
Which industry does the Perspective Therapeutics, Inc. company belong to?
The Perspective Therapeutics, Inc. industry is Medical Devices.
How many shares does Perspective Therapeutics, Inc. have in circulation?
The max supply of Perspective Therapeutics, Inc. shares is 623.52M.
What is Perspective Therapeutics, Inc. Price to Earnings Ratio (PE Ratio)?
Perspective Therapeutics, Inc. PE Ratio is now.
What was Perspective Therapeutics, Inc. earnings per share over the trailing 12 months (TTM)?
Perspective Therapeutics, Inc. EPS is -0.13 EUR over the trailing 12 months.
Which sector does the Perspective Therapeutics, Inc. company belong to?
The Perspective Therapeutics, Inc. sector is Healthcare.